Method of stimulating hematopoiesis with hemoglobin
Patent Number: 5631219
Date of First Priority Issue: Tuesday March 8th, 1994
Date Issued: Tuesday May 20th, 1997
Assignee: Somatogen, Inc. (Boulder, CO)
Inventors: Rosenthal, Gary J. (Boulder, CO); Gerber, Michael J. (Denver, CO)
From Class: Expansion
Comments: No comments
This patent teaches that hemoglobin itself may have hematopoietic stem cell stimulatory properties. The ability of hemoglobin chains has been described by others for stimulation of stem cell proliferation, and in some cases inhibition.
This patent covers purified hemoglobin, mutant hemoglobin, and various recombinant hemoglobins.
In Feb 25, 1998, Somatogen was bought by Baxter for 189 million dollars.
View this patent on the USPTO website.
Added to StemCellPatents.com on Monday October 16th, 2006
Social & Bookmarking:
Add Comment
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.